Bayer announced on April 21, 2020 that its Canadian branch is collaborating with the Population Health Research Institute (PHRI) to launch a clinical research program focused on identifying potential treatments against COVID-19. Bayer will provide CAD $1.5 million (USD$1 million) toward tw